Latest News

Independent Investment Research Report May 2017
AFR Editorial : Innovations in Cancer Research
Noxopharm Mid Year Investor Briefings
Request for Proposal: CRO Support for clinical trials

Noxopharm Limited are currently seeking proposals from interested CROs to support the management of late stage clinical trials. For further information, and a copy of the RFP, please click here.

Market Guidance for Next Six Months
Appendix 4C - quarterly
FNN Interview with NOX CEO Explaining Idronoxil-C Discovery
NOX Files Patent Application on 'Smart' Idronoxil
NOX and Monash Uni Collaboration Receives Federal Grant
Noxopharm and UNSW combine on stroke project